Clinical Trial Update: Bimekizumab in Plaque Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating bimekizumab for plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED